Welcure Drugs & Pharmaceuticals Reports Strong Financial Growth in June 2025 Results

Aug 05 2025 03:18 PM IST
share
Share Via
Welcure Drugs & Pharmaceuticals has announced its financial results for the quarter ending June 2025, revealing significant growth in net sales, profit before tax, and profit after tax. The company also reported its highest operating profit in five quarters and a peak earnings per share, indicating strong performance in the sector.
Welcure Drugs & Pharmaceuticals has recently reported its financial results for the quarter ending June 2025, showcasing significant developments within the company. The evaluation changes reflect a notable shift in the stock's score, which has risen to 32 from 16 over the past three months.

The financial data indicates that net sales for the latest six months reached Rs 321.12 crore, demonstrating a remarkable year-on-year growth. This positive sales trend is complemented by a substantial increase in profit before tax less other income (PBT), which stood at Rs 31.14 crore, marking a significant rise compared to the average of the previous four quarters. Similarly, profit after tax (PAT) also saw a considerable increase, reported at Rs 23.30 crore, again surpassing the previous quarter averages.

Additionally, the operating profit (PBDIT) reached its highest level in the last five quarters, further underscoring the company's strong performance. The earnings per share (EPS) also hit a peak at Rs 2.07, indicating enhanced profitability for shareholders.

These developments highlight the positive trajectory of Welcure Drugs & Pharmaceuticals in the pharmaceuticals and biotechnology sector.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News